# Staar Surgical Co (STAA)

> Staar Surgical Co (STAA) trades at $25.21 (-5.65%) as of 7:56:44 PM EST on Nov 6, 2026, +12.65% over the past month. Market cap is $1.27B, with 6.1 days to cover in short interest.

Canonical: https://massive.com/quote/staa
Data as of: 2026-11-07T00:56:44.101Z (15-minute delayed)
Source: Massive (https://massive.com/docs/llms.txt)

## Price

**$25.21** -1.51 (-5.65%)
At close · 15-minute delayed
Nasdaq · usd

After hours: **$25.00** -0.21 (-0.83%)
As of 7:56:44 PM EST on Nov 6, 2026 · After hours

## Stock performance

How Staar Surgical Co (STAA) stock has performed from one day to one year, with its 52-week range.

| Period | Return |
| --- | --- |
| 1D | -5.65% |
| 1W | +2.73% |
| 1M | +12.65% |
| YTD | +9.18% |
| 1Y | -8.03% |
| 52-wk range | $15.59 – $35.87 |

From daily closes through Nov 6, 2026.

## Key statistics

Today's trading snapshot for STAA: day range, open, previous close, volume and market cap.

| Measure | Value |
| --- | --- |
| Day range | $25.06 – $26.70 |
| Open | $26.41 |
| Prev close | $26.72 |
| Volume | 1.04M |
| Market cap | $1.27B |
| Shares out | 50.2M |

## Valuation and profitability ratios

Valuation and profitability ratios for Staar Surgical Co: P/E, P/S, P/B, ROE and more.

| Measure | Value |
| --- | --- |
| P/E | 2387.90 |
| P/S | 3.86 |
| P/B | 3.36 |
| P/FCF | 70.91 |
| ROE | 0.1% |
| ROA | 0.1% |
| Debt/Equity | 0.00 |
| Div yield | 0.00% |

As of Nov 6, 2026

## Insider trading

[Staar Surgical Co (STAA) insider trading](https://massive.com/quote/staa/insider-trading.md): open-market Form 4 buys and sells by Staar Surgical Co insiders over the last 12 months.

## 8-K filings

Material corporate events Staar Surgical Co has disclosed to the SEC on Form 8-K.

- Nov 4, 2026 · [Quarterly earnings](https://massive.com/quote/sec-filings/8-k/earnings-releases.md)
  “On November 4, 2026, STAAR Surgical Company (the "Company") published a press release reporting its financial results for the quarter ended October 2, 2026, a copy of which is furnished as Exhibit 99.1 to this report and is incorporated herein by this reference.”
- Sep 10, 2026 · Executive compensation change
  “In connection with his appointment as Chief Commercial Officer, Mr. Bailey executed an Offer Letter (the "Bailey Agreement") pursuant to which he will receive ... base salary at an annual rate of CHF 462,825 (approximately $575,000) ... eligibility to participate in the Company's annual cash bonus program with a target bonus for fiscal 2026 of 60% of his base salary.”
- Aug 6, 2026 · Executive compensation change
  “The equity component of Mr. Foust's CEO compensation consists of: (a) time-based stock options (20%), (b) time-based restricted stock units ("RSUs") (20%), and (c) performance-based stock options that have a time-vesting component (3 years), with a life of ten years, and are split into three stock price attainment hurdles - $50, $75, and $100 per share (each 20%). Pursuant to the Foust Agreement and certain 2026 award agreements entered into in connection with his appointment, Mr. Foust is entitled to receive the following grants: CEO Grant consisting of 22,493 time-vesting RSUs, 40,471 time-vesting options, and 131,830 performance-vesting options.”
- Jun 22, 2026 · Equity compensation grant
  “At the 2026 Annual Meeting, the Company's shareholders approved Amendment No. 2 to the STAAR Surgical Company Amended and Restated Omnibus Equity Incentive Plan (the "Plan") to increase the number of shares of common stock reserved for issuance thereunder by 3,900,000 shares (the "Plan Amendment").”
- Jun 9, 2026 · Executive compensation change
  “On June 8, 2026, the Compensation Committee approved an increase to the annual base salary of Deborah Andrews, the Company's Interim Co-Chief Executive Officer and Chief Financial Officer from $512,000 to $575,000. In addition, the Committee approved an increase in the target annual cash bonus for Ms. Andrews from 55% to 60% of her base salary.”

## STAA short interest

How heavily STAA is shorted: shares short, days to cover and average daily volume.

| Measure | Value |
| --- | --- |
| Days to cover | 6.1 |
| Short interest | 3.7M |
| Avg volume | 605K |

As of Oct 15, 2026 · reported to FINRA twice monthly.

## STAA news

The latest news and headlines about Staar Surgical Co (STAA).

- [Merit Medical (MMSI) Q3 Earnings and Revenues Beat Estimates](https://www.zacks.com/stock/news/3019184/merit-medical-mmsi-q3-earnings-and-revenues-beat-estimates?cid=CS-ZC-FT-fundamental_analysis|yseop_template_4-3019184) · Zacks Investment Research · Oct 29, 2026 · neutral sentiment
- [Why Staar Surgical Zoomed Almost 8% Higher on Tuesday](https://www.fool.com/investing/2026/09/29/why-staar-surgical-zoomed-almost-8-higher-on-tuesd/?source=iedfolrf0000001) · The Motley Fool · Sep 29, 2026 · positive sentiment
- [Why Staar Surgical Stock Soared Today](https://www.fool.com/investing/2026/09/25/why-staar-surgical-stock-soared-today/?source=iedfolrf0000001) · The Motley Fool · Sep 25, 2026 · positive sentiment
- [Why Did STAAR Surgical (STAA) Stock Jump 20% After Hours?](https://www.benzinga.com/markets/equities/26/04/51723266/why-did-staar-surgical-staa-stock-jump-20-after-hours?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel) · Benzinga · Apr 9, 2026 · positive sentiment
- [LENSAR Stock Plunges—Alcon Scraps Merger After Prolonged Regulatory Review](https://www.benzinga.com/m-a/26/03/51295082/lensar-stock-plunges-alcon-scraps-merger-after-prolonged-regulatory-review?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel) · Benzinga · Mar 17, 2026 · negative sentiment

## About Staar Surgical Co

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.

| Measure | Value |
| --- | --- |
| Exchange | Nasdaq |
| Market | stocks |
| Type | CS |
| Currency | USD |
| Industry | OPHTHALMIC GOODS |
| Employees | 957 |
| Listed | Jul 7, 1983 |

[Company website](https://www.staar.com)

## FAQ

### What is the Staar Surgical Co (STAA) stock price today?

Staar Surgical Co (STAA) is trading at $25.21 (-5.65% on the day) as of 7:56:44 PM EST on Nov 6, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

### What is Staar Surgical Co?

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye.

### What is the short interest in STAA?

As of Oct 15, 2026, STAA has 3.7M shares short and 6.1 days to cover.

### What exchange is STAA listed on?

Staar Surgical Co (STAA) trades on Nasdaq in USD, in the OPHTHALMIC GOODS industry.

## Live data

Prices here are 15-minute delayed. For real-time STAA quotes and the full history behind this page, use the Massive API or MCP server:

- `GET https://api.massive.com/v3/snapshot?ticker.any_of=STAA`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [Staar Surgical Co (STAA) insider trading](https://massive.com/quote/staa/insider-trading.md)
- [SEC 8-K events](https://massive.com/quote/sec-filings/8-k.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms
